Spryng with OsteoCushion Technology Syringes

PETVIVO HOLDINGS INC
Overview Spryng™ with OsteoCushion™ Technology Syringes are indicated for horses, dogs, and cats to aid in the management of noninfectious sources of joint pain including, but not limited to, degenerative joint disease, osteoarthritis, joint instability, and lameness.

  • Intra-articular injectable veterinary medical device that promotes restoration of proper joint mechanics by adding natural, viscosolid matrices to the joint’s synovial fluid
  • Spryng is composed of a protein-carbohydrate matrix made from purified, natural biomaterials using a proprietary, patented process
  • Engineered and designed to provide a bio-integrative scaffold in the affected joint
  • A single treatment provides long-duration joint benefits
  • The biocompatible dispersion of viscoelastic particles are composed of two purified
  • proteins (collagen, elastin) and a purified carbohydrate (heparin glycan) that self-assemble to form a sterile, insoluble, and pliable matrix
  • Achieves its intended purpose without pharmacologic, chemical, or metabolic action
  • Pre-filled syringes are provided in peelable pouches and appropriate for use in a surgical/sterile field
  • Multiple joints may be injected as part of the same procedure
  • a 26-month shelf life at room temperature (40F to 90F)